RGLS
Regulus Therapeutics Inc.
Director Stelios Papadopoulos bought $400K of Regulus Therapeutics Inc.
Bought$400,000
$1.08Price
370,370Shares
+45%Stake
What RGLS did for a copier
Prices for RGLS after this filing aren't in yet.
Stelios Papadopoulos's record
5 other buys on record. A record shows here once 3 of them have 3 months of prices.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Tue, May 7. Filed Wed, May 8, 5:13 PM ET, after the close. Not investment advice.